User login
Randomized Trial Evaluating a New 0.5% Fluorouracil Formulation Demonstrates Efficacy After 1-, 2-, or 4-Week Treatment in Patients With Actinic Keratosis
Article Type
              
          Changed
              Thu, 01/10/2019 - 11:57
          Display Headline
              Randomized Trial Evaluating a New 0.5% Fluorouracil Formulation Demonstrates Efficacy After 1-, 2-, or 4-Week Treatment in Patients With Actinic Keratosis
          Article PDF
              
          Issue
              Cutis - 70(6)
          Publications
          
      Topics
          
      Page Number
              335-339
          Sections
          
      Article PDF
              
          Article PDF
              
          Issue
              Cutis - 70(6)
          Issue
              Cutis - 70(6)
          Page Number
              335-339
          Page Number
              335-339
          Publications
          
      Publications
          
      Topics
          
      Article Type
              
          Display Headline
              Randomized Trial Evaluating a New 0.5% Fluorouracil Formulation Demonstrates Efficacy After 1-, 2-, or 4-Week Treatment in Patients With Actinic Keratosis
          Display Headline
              Randomized Trial Evaluating a New 0.5% Fluorouracil Formulation Demonstrates Efficacy After 1-, 2-, or 4-Week Treatment in Patients With Actinic Keratosis
          Sections
          
      Article Source
              PURLs Copyright
              Inside the Article
              Article PDF Media
              Document